Biblio

Found 12 results
Filters: Author is Lolli, G.  [Clear All Filters]
2026
A. Vedove D, Cazzanelli G., D'Agostino V.G, Vargas-Rosales P.A, Caflisch A., Lolli G..  2026.  Unusual Backfolded Binding Poses of BAZ2A Bromodomain Binders. Acta Crystallographica Section D, Structural Biology. 82(7):1-9.
2024
Cazzanelli G., A. Vedove D, Sbardellati N., Valer L., Caflisch A., Lolli G..  2024.  Enhanced cellular death in liver and breast cancer cells by dual BET/BRPF1 inhibitors. Protein Science. 33(11):e5191.
2023
A. Vedove D, Cazzanelli G., Corsi J., Sedykh M., Batiste L., Marchand J.-R., Spiliotopoulos D., D'Agostino V.G., Caflisch A., Lolli G..  2023.  Identification of BAZ2A bromodomain hit compounds. Acta Crystallographica Section A: Foundations of Crystallography. 78(X):a418-a418.
Cazzanelli G., Vedove A.D., Parolin E., D'Agostino V.G., Unzue A., Nevado C., Caflisch A., Lolli G..  2023.  Reevaluation of bromodomain ligands targeting BAZ2A. Protein Science. 32(9):e4752.
2022
Dalle Vedove A., Cazzanelli G., Batiste L., Marchand J.-R., Spiliotopoulos D., Corsi J., D’Agostino V.G, Caflisch A., Lolli G..  2022.  Identification of a BAZ2A-bromodomain hit compound by fragment growing. ACS Medicinal Chemistry Letters. 13(9):1434-1443.
2021
Dalle Vedove A., Cazzanelli G., Corsi J., Sedykh M., D'Agostino V.G, Caflisch A., Lolli G..  2021.  Identification of a BAZ2A bromodomain hit compound by fragment joining. ACS Bio & Med Chem Au. 1(1):5-10.
2018
Dalle Vedove A., Spiliotopoulos D., D'Agostino V.G, Marchand J.-R., Unzue A., Nevado C., Lolli G., Caflisch A..  2018.  Structural analysis of small molecule binding to the BAZ2A and BAZ2B bromodomains. ChemMedChem. 13(14):1479-1487.
2017
Spiliotopoulos D., Wamhoff E.-C., Lolli G., Rademacher C., Caflisch A..  2017.  Discovery of BAZ2A bromodomain ligands. European Journal of Medicinal Chemistry. 139:564-572.
Marchand J.-R., Dalle Vedove A., Lolli G., Caflisch A..  2017.  Discovery of inhibitors of four bromodomains by fragment-anchored ligand docking. Journal of Chemical Information and Modeling. 57(10):2584-2597.
2016
Marchand J.-R., Lolli G., Caflisch A..  2016.  Derivatives of 3-amino-2-methylpyridine as BAZ2B bromodomain ligands: In silico discovery and in crystallo validation. Journal of Medicinal Chemistry. 59(21):9919-9927.
Unzue A., Zhao H., Lolli G., Dong J., Zhu J., Zechner M., Dolbois A., Caflisch A., Nevado C..  2016.  The "gatekeeper" residue influences the mode of binding of acetyl indoles to bromodomains. Journal of Medicinal Chemistry. 59(7):3087-3097.
Lolli G., Caflisch A..  2016.  High-throughput fragment docking into the BAZ2B bromodomain: Efficient in silico screening for X-Ray crystallography. ACS Chemical Biology. 11(3):800-807.